Singapore-based VentureBlick, a global venture platform for healthcare innovation, has announced the successful closure of its first two deals, securing a total of $2.6 million for two startups despite a challenging funding environment. 

Building on this success, VentureBlick is evolving its business model into a 'Super Incubator' model, which provides an end-to-end, fully customisable solution to help build, test, and market medtech innovations, with successful exits or commercialisation as the ultimate goal. VentureBlick will officially launch its Super Incubator in September 2023 and is currently raising funds for the new model. 

As part of its new model, VentureBlick is also launching its medical advisory business, offering expertise in evaluating investments or M&A deals from a medical perspective on behalf of corporate ventures, VCs, or government bodies. One of the largest corporate conglomerates in the world has retained VentureBlick to assess its potential investment deals in the healthcare sector. They will tap into VentureBlick's global advisory network, which consists of more than 1,000 advisors who have been individually screened and vetted from more than 50 countries covering over 30 specialty areas. The advisor pool will be further expanded to 3,000 by the end of 2023.